Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 12;12(6):e8574.
doi: 10.7759/cureus.8574.

The Future of Concurrent Automated Coronary Artery Calcium Scoring on Screening Low-Dose Computed Tomography

Affiliations
Review

The Future of Concurrent Automated Coronary Artery Calcium Scoring on Screening Low-Dose Computed Tomography

Jeffrey Waltz et al. Cureus. .

Abstract

Low-dose computed tomography (LDCT) has been extensively validated for lung cancer screening in selected patient populations. Additionally, the use of gated cardiac CT to assess coronary artery calcium (CAC) burden has been validated to determine a patient's risk for major cardiovascular adverse events. This is typically performed by calculating an Agatston score based on density and overall burden of calcified plaque within the coronary arteries. Patients that qualify for LDCT for lung cancer screening commonly share major risk factors for coronary artery disease and would frequently benefit from an additional gated cardiac CT for the assessment of CAC. Given the widespread use of LDCT for lung cancer screening, we evaluated current literature regarding the use of non-gated chest CT, specifically LDCT, for the detection and grading of coronary artery calcifications. Additionally, given the evolving and increasing use of artificial intelligence (AI) in the interpretation of radiologic studies, current literature for the use of AI in CAC assessment was reviewed. We reviewed primary scientific literature dating up to April 2020 using Pubmed and Google Scholar, with the search terms low dose CT, lung cancer screening, coronary artery calcium, EKG/cardiac gated CT, deep learning, machine learning, and AI. These publications were then independently evaluated by each member of our team. Overall, there was a consensus within these papers that LDCT for lung cancer screening plays a role in the evaluation of CAC. Most studies note the inherent problems with the evaluation of the density of coronary calcifications on LDCT to give an accurate numeric calcium or Agatston score. The current method of evaluating CAC on LDCT involves using a qualitative categorical system (none, mild, moderate, or severe). When performed by cardiac imaging experts, this method broadly correlates with traditional CAC score groups (0, 1 to 100, 101 to 400, and > 400). Furthermore, given the high sensitivity of a properly protocolled LDCT for coronary calcium, a negative study for CAC precludes the need for a dedicated gated CT assessment. However, qualitative methods are not as accurate or reproducible when performed by general radiologists. The implementation of AI in the LDCT screening process has the potential to give a quantifiable and reproducible numeric value to the calcium score, based on whole heart volume scoring of calcium. This more closely aligns with the Agatston score and serves as a better guide for treatment and risk assessment using current guidelines. We conclude that CAC should be assessed on all LDCT performed for lung cancer screening and that a qualitative categorical scoring system should be provided in the impression for each patient. Early studies involving AI for the assessment of CAC are promising, but more extensive studies are needed before a final recommendation for its use can be given. The implementation of an accurate, automated AI CAC assessment tool would improve radiologist compliance and ease of overall workflow. Ultimately, the potential end result would be improved turnaround time, better patient outcomes, and reduced healthcare costs by maximizing preventative care in this high-risk population.

Keywords: agatston score; artificial intelligence; cardiovascular disease; categorical; coronary artery calcium; deep learning; low dose chest ct screening; lung cancer screening.

PubMed Disclaimer

Conflict of interest statement

Title: Volumetric quantification of cardiovascular structures from medical imaging. US patent #: 9968257 Inventor: Jeremy R Burt

Figures

Figure 1
Figure 1. American Heart Association and American College of Cardiology guidelines for primary prevention of atherosclerotic cardiovascular disease (ASCVD)
Determination of CAC is included for patients at “intermediate risk.” ABI: ankle-brachial index; apoB: apolipoprotein B; ASCVD: atherosclerotic cardiovascular disease; CAC: coronary artery calcium; CHD: coronary heart disease; HIV: human immunodeficiency virus; hs-CRP: high-sensitivity C-reactive protein; LDL-C: low- density lipoprotein cholesterol; Lp(a): lipoprotein (a) Reproduced with permission from Grundy et al. [18], copyright © 2018, American Heart Association, Inc. and American College of Cardiology Foundation.
Figure 2
Figure 2. Example of cardiac motion artifact
Axial noncontrast-enhanced, non-ECG gated chest CT images performed at our institution for lung cancer screening demonstrating the effect of cardiac motion artifact (arrows). Left anterior descending artery motion is characterized by a smudged appearance (A). The right coronary artery is the most commonly affected epicardial artery (B, C, and D) with artifactual duplication of the vessel. ECG: electrocardiogram; CT: computed tomography
Figure 3
Figure 3. Example of an artificial neural network framework used to automatically detect the coronary artery calcium score from non-contrast chest CT
IC (contrast image after preprocessing), INC (noncontrast image), MAorta_C, MHeart_C, MArtery_C (segmentation results of the aorta, heart, and coronary arteries in the contrasted image), MCalc_NC (the patient-specific ROI for calcification detection defined on the noncontrast image) Reproduced with permission from Sandstedt et al [41], copyright © 2019, European Radiology http://creativecommons.org/licenses/by/4.0/
Figure 4
Figure 4. Bland Altman analyses showing the difference in coronary calcium score between AI software and standard reference, plotted against the mean of the coronary calcium measurements
The red line represents mean differences with the upper and lower limits of agreement with a 95% confidence interval in green. (a) Agatston score mean difference of -8.2 (limits of agreement -115 to 98.2), (b) volume score mean difference of -7.2 (limits of agreement -7.2 to 79.1), and (c) mass score mean difference of -3.8 (limits of agreement -33.6 to 25.9). AI: artificial intelligence Reproduced with permission from Yang et al [42], copyright © 2016, Medical Physics, John Wiley and Sons.
Figure 5
Figure 5. Miscategorized calcifications by AI software
LDCT examinations performed at our institution in patients with different examples of calcifications that may be miscategorized as coronary artery calcifications by AI software. (A) Aortic annulus calcifications, (B) mitral annulus calcifications, and (C) pericardial calcifications, all have the potential to be misidentified, and deep learning algorithms must have the ability to account for calcification location. AI: artificial intelligence; LDCT: low-dose computed tomography

Similar articles

Cited by

References

    1. Cancer statistics, 2020. Siegel RL, Miller KD, Jemal A. CA Cancer J Clin. 2020;70:7–30. - PubMed
    1. Primary and subsequent coronary risk appraisal: new results from the Framingham study. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC. https://pubmed.ncbi.nlm.nih.gov/10650300/ Am Heart J. 2000;139:272–281. - PubMed
    1. Results of initial low-dose computed tomographic screening for lung cancer. Church TR, Black WC, Aberle DR, et al. N Engl J Med. 2013;368:1980–1991. - PMC - PubMed
    1. Reduced lung-cancer mortality with low-dose computed tomographic screening. Aberle DR, Adams AM, Berg CD, et al. N Engl J Med. 2011;365:395–409. - PMC - PubMed
    1. Survival of patients with stage I lung cancer detected on CT screening. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. N Engl J Med. 2006;355:1763–1771. - PubMed

LinkOut - more resources